Suppr超能文献

沉默的长链非编码 RNA COL18A1-AS1 通过脂肪棕色化调控 miR-1286/KLF12 轴抑制 ccRCC 进展。

Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis.

机构信息

Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.

Institute of Urology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.

出版信息

Cell Death Dis. 2022 Jul 4;13(7):578. doi: 10.1038/s41419-022-04996-2.

Abstract

Abnormal accumulation of lipids has been highlighted in the progression of clear cell renal cell carcinoma (ccRCC). However, the underlying mechanism remains unclear. Emerging evidence suggests long noncoding RNAs (lncRNAs) participate in the regulation of lipid metabolism. In this study, we found lncRNA COL18A1-AS1 was downregulated in ccRCC and that higher COL18A1-AS1 expression indicated better prognosis. Decreased COL18A1-AS1 expression was caused by DNA methylation at the CpG islands within its promoter. Restoring the epigenetically silenced COL18A1-AS1 repressed tumor progression, promoted lipid browning and consumption in vitro and in vivo. Mechanistically, COL18A1-AS1 could competitively bind miR-1286 to increase the expression of Krüppel-like factor 12 (KLF12). Downregulation of COL18A1-AS1 in ccRCC resulted in the low expression of KLF12. COL18A1-AS1/KLF12 positively regulated uncoupling protein 1 (UCP1)-mediated lipid browning, which promotes tumor cell "slimming" and inhibits tumor progression. When tumor cell "slimming" occurred, lipid droplets turned into tiny pieces, and lipids were consumed without producing ATP energy. Taken together, our findings on COL18A1-AS1-miR-1286/KLF12 axis revealed a potential mechanism of abnormal accumulation of lipids in ccRCC and could be a promising therapeutic target for ccRCC patients.

摘要

脂质异常积累在透明细胞肾细胞癌(ccRCC)的进展中已得到突出强调。然而,其潜在机制尚不清楚。新出现的证据表明,长非编码 RNA(lncRNA)参与了脂质代谢的调节。在本研究中,我们发现 lncRNA COL18A1-AS1 在 ccRCC 中表达下调,并且 COL18A1-AS1 表达越高,预后越好。COL18A1-AS1 表达的降低是由其启动子内 CpG 岛上的 DNA 甲基化引起的。恢复 COL18A1-AS1 的表观遗传沉默可抑制肿瘤的体外和体内进展,促进脂质褐变和消耗。从机制上讲,COL18A1-AS1 可以与 miR-1286 竞争结合,从而增加 Krüppel 样因子 12(KLF12)的表达。ccRCC 中 COL18A1-AS1 的下调导致 KLF12 表达降低。COL18A1-AS1/KLF12 正向调节解偶联蛋白 1(UCP1)介导的脂质褐变,促进肿瘤细胞“瘦身”并抑制肿瘤进展。当肿瘤细胞“瘦身”发生时,脂质滴变成小块,并且在不产生 ATP 能量的情况下消耗脂质。总之,我们对 COL18A1-AS1-miR-1286/KLF12 轴的研究结果揭示了 ccRCC 中脂质异常积累的潜在机制,可能成为 ccRCC 患者有前途的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec90/9253045/07fb5bd41b79/41419_2022_4996_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验